Home
CLSD
CLSD News

Latest Clearside Biomedical Inc. (CLSD) News on October 30, 2025

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

GlobeNewswire

4 months ago

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know

Zacks

5 months ago

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

GlobeNewswire

5 months ago

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

6 months ago

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

GlobeNewswire

6 months ago

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

GlobeNewswire

6 months ago

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know

Zacks

6 months ago

Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire

6 months ago

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Clearside Biomedical Inc (CLSD) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com

7 months ago

Clearside Biomedical Inc (CLSD) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

7 months ago

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Clearside Biomedical Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

7 months ago

Clearside Biomedical Full Year 2024 Earnings: In Line With Expectations

Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates

Zacks

7 months ago

Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

7 months ago

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

GlobeNewswire

7 months ago

Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit

GlobeNewswire

7 months ago

Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit

Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025

GlobeNewswire

8 months ago

Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025

Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

GlobeNewswire

8 months ago

Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

Zai Lab Limited (ZLAB) Surges 9.0%: Is This an Indication of Further Gains?

Zacks

8 months ago

Zai Lab Limited (ZLAB) Surges 9.0%: Is This an Indication of Further Gains?

Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema

GlobeNewswire

8 months ago

Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema

Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting

GlobeNewswire

9 months ago

Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting

Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference

GlobeNewswire

9 months ago

Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference

Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery and Key Differentiators in its CLS-AX Clinical Program

GlobeNewswire

9 months ago

Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery and Key Differentiators in its CLS-AX Clinical Program

MT Newswires

9 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires

9 months ago

Clearside's Partner Receives NDA Approvals for Uveitic Macular Edema Treatment in Australia, Singapore

Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

GlobeNewswire

9 months ago

Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

Clearside announces publication of insights on drug development, regulation

TipRanks

10 months ago

Clearside announces publication of insights on drug development, regulation

Analyst Sees 500% Upside for This Pharmaceutical Penny Stock

GuruFocus.com

10 months ago

Analyst Sees 500% Upside for This Pharmaceutical Penny Stock

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

GlobeNewswire

10 months ago

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now

Zacks

a year ago

Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

GlobeNewswire

a year ago

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy

Zacks

a year ago

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...

GuruFocus.com

a year ago

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a year ago

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For

GuruFocus.com

a year ago

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For

Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

Simply Wall St.

a year ago

Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

Santen, Arctic Vision sign deal for ARVN001 to treat UME

Pharmaceutical Technology

a year ago

Santen, Arctic Vision sign deal for ARVN001 to treat UME

MT Newswires

a year ago

Clearside's Partner Arctic Vision Enters Collaboration With Santen Pharma for Uveitic Macular Edema Treatment

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

GlobeNewswire

a year ago

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

GlobeNewswire

a year ago

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

GlobeNewswire

a year ago

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

GlobeNewswire

a year ago

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

GlobeNewswire

a year ago

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

Morning Movers: Arcadium Lithium surges after deal to be acquired

TipRanks

a year ago

Morning Movers: Arcadium Lithium surges after deal to be acquired

Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Benzinga

a year ago

Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Top Premarket Gainers

MT Newswires

a year ago

Clearside Biomedical Shares Rise After Phase 2B Trial of Potential Eye Degeneration Treatment Shows Positive Data

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

GlobeNewswire

a year ago

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

GlobeNewswire

a year ago

Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

MT Newswires

a year ago

Chardan Research Initiates Clearside Biomedical at Buy With $6 Price Target

After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)

Zacks

a year ago

After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Zacks

a year ago

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire

a year ago

Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

a year ago

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

GlobeNewswire

a year ago

Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China

GlobeNewswire

a year ago

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China

Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET

GlobeNewswire

a year ago

Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

GlobeNewswire

a year ago

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

GlobeNewswire

a year ago

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

MT Newswires

a year ago

Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

GlobeNewswire

a year ago

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Reuters

a year ago

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Newsfile

a year ago

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

BW Energy: Mandatory notifications of trade by primary insiders and close associates

GlobeNewswire

a year ago

BW Energy: Mandatory notifications of trade by primary insiders and close associates

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

GlobeNewswire

a year ago

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

Sage Potash Grants Stock Options

CNW Group

a year ago

Sage Potash Grants Stock Options

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

ACCESSWIRE

a year ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

ACCESSWIRE

a year ago

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

GlobeNewswire

a year ago

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago

Simply Wall St.

a year ago

Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

GlobeNewswire

a year ago

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

MT Newswires

a year ago

HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating

Thomson Reuters StreetEvents

a year ago

Q1 2024 Clearside Biomedical Inc Earnings Call

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

GlobeNewswire

a year ago

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

GlobeNewswire

a year ago

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

GlobeNewswire

2 years ago

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

2 years ago

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

GlobeNewswire

2 years ago

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

2 years ago

Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Clearside Biomedical Inc Earnings Call

Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...

GuruFocus.com

2 years ago

Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts

TipRanks

2 years ago

These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

GlobeNewswire

2 years ago

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

InvestorPlace

2 years ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Argus Research

2 years ago

Daily – Vickers Top Buyers & Sellers for 02/12/2024

Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock

Simply Wall St.

2 years ago

Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

GlobeNewswire

2 years ago

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 years ago

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Washington Trust Bancorp, Inc. (NASDAQ:WASH) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Washington Trust Bancorp, Inc. (NASDAQ:WASH) Q4 2023 Earnings Call Transcript

Share on Social Networks: